Clinical trial
Clinical Efficacy of Megadose Vitamin C in Sepsis (CEMVIS): A Multicenter, Randomized, Single-blind, Placebo-controlled Clinical Trial
NCT05194189 is registered in ClinicalTrials.gov with Zhujiang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Efficacy of Megadose Vitamin C in Sepsis (CEMVIS): A Multicenter, Randomized, Single-blind, Placebo-controlled Clinical Trial
- Lead sponsor
- Zhujiang Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 8, 2022
- Completion date
- December 25, 2024
- Enrollment
- 234 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
sepsis, septic shock